CY1110605T1 - Διαδικασια για την παρασκευη ενωσεων πυριμιδινης - Google Patents

Διαδικασια για την παρασκευη ενωσεων πυριμιδινης

Info

Publication number
CY1110605T1
CY1110605T1 CY20101100025T CY101100025T CY1110605T1 CY 1110605 T1 CY1110605 T1 CY 1110605T1 CY 20101100025 T CY20101100025 T CY 20101100025T CY 101100025 T CY101100025 T CY 101100025T CY 1110605 T1 CY1110605 T1 CY 1110605T1
Authority
CY
Cyprus
Prior art keywords
compound
formula
preparation
alkyl
group
Prior art date
Application number
CY20101100025T
Other languages
Greek (el)
English (en)
Inventor
Lee Newton
Mark Bailey
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229243A external-priority patent/GB0229243D0/en
Priority claimed from GB0303589A external-priority patent/GB0303589D0/en
Priority claimed from GB0318515A external-priority patent/GB0318515D0/en
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of CY1110605T1 publication Critical patent/CY1110605T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY20101100025T 2002-12-16 2010-01-11 Διαδικασια για την παρασκευη ενωσεων πυριμιδινης CY1110605T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0229243A GB0229243D0 (en) 2002-12-16 2002-12-16 Compounds and process
GB0303589A GB0303589D0 (en) 2003-02-17 2003-02-17 Compounds and process
GB0318515A GB0318515D0 (en) 2003-08-07 2003-08-07 Compounds and process
EP03780362A EP1578731B1 (en) 2002-12-16 2003-12-09 Process for the preparation of pyrimidine compounds

Publications (1)

Publication Number Publication Date
CY1110605T1 true CY1110605T1 (el) 2015-04-29

Family

ID=32600665

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100025T CY1110605T1 (el) 2002-12-16 2010-01-11 Διαδικασια για την παρασκευη ενωσεων πυριμιδινης

Country Status (22)

Country Link
US (2) US7524955B2 (https=)
EP (2) EP1578731B1 (https=)
JP (2) JP4579821B2 (https=)
KR (1) KR101060215B1 (https=)
AR (1) AR042355A1 (https=)
AT (1) ATE448209T1 (https=)
AU (1) AU2003288443B2 (https=)
BR (1) BR0317313A (https=)
CA (1) CA2509344C (https=)
CY (1) CY1110605T1 (https=)
DE (1) DE60330050D1 (https=)
DK (1) DK1578731T3 (https=)
ES (1) ES2335279T3 (https=)
IL (1) IL168884A (https=)
MX (1) MXPA05006425A (https=)
MY (1) MY138051A (https=)
NO (2) NO330983B1 (https=)
NZ (1) NZ540722A (https=)
PT (1) PT1578731E (https=)
SI (1) SI1578731T1 (https=)
TW (1) TWI322145B (https=)
WO (1) WO2004054986A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
MXPA04000322A (es) * 2001-07-13 2005-09-08 Astrazeneca Uk Ltd Preparacion de compuestos de aminopirimidina.
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR20030092446A (ko) * 2002-05-29 2003-12-06 주식회사 한국토종약초연구소 씨형 간염 활성 억제를 갖는 조릿대 추출물을 포함하는조성물
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR101060215B1 (ko) 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US8153791B2 (en) * 2005-12-21 2012-04-10 Janssen Pharmaceutica N.V. Substituted pyrimidinyl oxime kinase inhibitors
US8013153B2 (en) * 2006-03-23 2011-09-06 Janssen Pharmaceutica, N.V. Substituted pyrimidine kinase inhibitors
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
CN103004028B (zh) 2010-05-21 2016-04-06 库柏技术公司 用于套管闭锁的适配件

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278001A (en) * 1965-02-02 1966-10-11 Charles C Andrews Bearing assembly for auger conveyors
US4698340A (en) * 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4689414A (en) * 1986-02-24 1987-08-25 E. R. Squibb & Sons, Inc. 2-(substituted imino)-6-aryl-3,6-dihydro-4-substituted-1,5(2H)-pyrimidinecarboxylic acids and analogs
AU3214689A (en) 1988-10-06 1990-05-01 Sandoz Ag Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
FR2665159B1 (fr) 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
JP3197971B2 (ja) * 1993-03-01 2001-08-13 塩野義製薬株式会社 5−カルボアルコキシピリミジン誘導体の合成方法
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
MX9703518A (es) 1994-11-16 1997-08-30 Synaptic Pharma Corp Dihidropirimidinas y usos de las mismas.
DE19517186A1 (de) 1995-05-11 1996-11-14 Bayer Ag Verfahren zur Herstellung substituierter 2-Fluor-pyrimidine
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
WO1997021687A1 (en) 1995-12-14 1997-06-19 Merck & Co., Inc. Process for making dihydropyrimidinones
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
SE9702563D0 (sv) * 1997-07-02 1997-07-02 Astra Ab Compounds
CA2297889A1 (en) 1997-08-05 1999-02-18 Norihiro Ikemoto Alpha 1a adrenergic receptor antagonist
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
WO2000078730A1 (en) * 1999-06-23 2000-12-28 Ajinomoto Co., Inc. Novel dihydropyrimidine derivatives
US6579984B1 (en) 1999-07-13 2003-06-17 Lonza Ag Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AU2000254249A1 (en) 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
GB0011163D0 (en) 2000-05-10 2000-06-28 Astrazeneca Ab Chemical compound
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
MXPA04000322A (es) * 2001-07-13 2005-09-08 Astrazeneca Uk Ltd Preparacion de compuestos de aminopirimidina.
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR101060215B1 (ko) 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
CA2550742A1 (en) 2003-12-24 2005-07-14 Teva Pharmaceutical Industries Ltd. Process for preparation of statins with high syn to anti ratio
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
WO2004054986A2 (en) 2004-07-01
PT1578731E (pt) 2010-01-12
BR0317313A (pt) 2005-11-08
AU2003288443B2 (en) 2007-10-25
KR101060215B1 (ko) 2011-08-29
DE60330050D1 (de) 2009-12-24
WO2004054986A8 (en) 2005-07-21
EP2088142A3 (en) 2010-04-21
US8273878B2 (en) 2012-09-25
AR042355A1 (es) 2005-06-15
TWI322145B (en) 2010-03-21
JP2006515600A (ja) 2006-06-01
HK1080477A1 (en) 2006-04-28
US7524955B2 (en) 2009-04-28
EP2088142A2 (en) 2009-08-12
US20090264654A1 (en) 2009-10-22
MXPA05006425A (es) 2005-08-19
NO20052781L (no) 2005-07-07
CA2509344A1 (en) 2004-07-01
ES2335279T3 (es) 2010-03-24
JP2010248222A (ja) 2010-11-04
JP5318037B2 (ja) 2013-10-16
EP1578731B1 (en) 2009-11-11
US20060052604A1 (en) 2006-03-09
CA2509344C (en) 2011-10-04
SI1578731T1 (sl) 2010-02-26
NO20110366L (no) 2005-07-07
KR20050085674A (ko) 2005-08-29
IL168884A (en) 2011-01-31
MY138051A (en) 2009-04-30
WO2004054986A3 (en) 2004-12-02
TW200418809A (en) 2004-10-01
NO330983B1 (no) 2011-08-29
EP1578731A2 (en) 2005-09-28
ATE448209T1 (de) 2009-11-15
NZ540722A (en) 2008-03-28
AU2003288443A1 (en) 2004-07-09
DK1578731T3 (da) 2010-02-15
JP4579821B2 (ja) 2010-11-10

Similar Documents

Publication Publication Date Title
CY1110605T1 (el) Διαδικασια για την παρασκευη ενωσεων πυριμιδινης
TR200402300T4 (tr) İmidazopirimidin türevleri ve triazolopirimidin türevleri.
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
CY1116298T1 (el) Ενωσεις 3,4-διυποκατεστημενου 1η-πυραζολιου και χρηση αυτων ως ρυθμιστες κινασων που εξαρτωνται απο κυκλινη (cdk) και κινασης-3 συνθασης γλυκογονου (gsk-3)
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
CY1108652T1 (el) Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
CY1109882T1 (el) Νεα αλατα ατορβαστατινης και φαρμακευτικες συνθεσεις που τα περιεχουν
CY1109300T1 (el) Νεοι συντηγμενοι ετεροκυκλικοι δακτυλιοι και χρησεις αυτων
CY1116540T1 (el) Μεθοδος παραγωγης 2'-δεοξυ-5-αζακυτιδινης (δεσιταβινη)
CY1106677T1 (el) Παρασκευη ν1-(2’-πυριδυλ)-1, 2-προπανοδιαμινο σουλφαμικου οξεος και χρηση αυτου στη συνθεση βιολογικως δραστικων πιπεραζινων
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
ES8507111A1 (es) Un procedimiento para la preparacion de compuestos de 1,4-dihidropiridina.
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
EA200600046A1 (ru) Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
DE60016936D1 (de) Verflüssigungsmittel
ES2109236T3 (es) Reactivos tioacilantes y compuestos intermedios, tiopeptidos, y metodos para prepararlos y utilizarlos.
CY1110038T1 (el) 4-(διαρυλομεθυλ)-1- πιπεραζινυλ παραγωγα
HUP0001245A1 (hu) Új eritromicinszármazékok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk
CY1107805T1 (el) Στερεοεκλεκτικη μεθοδος παρασκευης νουκλεοζιτικων παραγωγων
DE60237652D1 (de) Variolinderivate und ihre Verwendung als Cytostatika
ES557208A0 (es) Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina
BR0105801B1 (pt) processo para produÇço de derivado alquilamina substituÍdo.
ES2161602A1 (es) Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilinato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.